Association of hyperlipidemia with breast cancer in Bangladeshi women

Abstract

Background: The association of circulating lipids with breast cancer is being debated. The objective of this study was to examine the relationship between abnormal plasma lipids and breast cancer risk in Bangladeshi women.

Methods: This was a case-control study designed using a population of 150 women (50 women in each group). The lipid levels of women with breast cancer were compared to the lipid levels of women with benign breast disease (control group 1) and healthy women (control group 2). Study samples were collected from the Department of Surgery, Bangabandhu Sheikh Mujib Medical University, for a period of 1 year. Ethical measures were in compliance with the current Declaration of Helsinki. Statistical analysis was performed with SPSS version 26.

Results: All of the comparison groups shared similar sociodemographic, anthropometric and obstetric characteristics. The incidence of dyslipidemia was significantly higher in breast cancer patients (96%) than in healthy women (84%) and patients with benign breast disease (82%) (P < 0.05 for both). The levels of total cholesterol, triglycerides, and low-density lipoprotein (LDL) cholesterol among the breast cancer patient group were significantly higher than those among both benign breast disease patients and healthy women (P < 0.05), except for high-density lipoprotein (HDL) cholesterol. Adjusting for other factors, body mass index (BMI) (kg/m²) (> 23) [OR 53.65; 95% CI: 5.70-504.73; P < 0.001] and total cholesterol (mg/dl) (≥ 200) [OR 16.05; 95% CI: 3.13-82.29; P < 0.001] were independently associated with breast cancer.

Conclusions: Total cholesterol and BMI are independent predictors of breast cancer risk among Bangladeshi women.

Keywords: Breast cancer; Cholesterol; Hyperlipidemia; Lipoprotein; Malignancy.

Fig. 1

Overall and group specific proportion of dyslipidemia. (Dyslipidemia was defined as having an abnormal value in one or more of the four components of lipid profile. p-value as determined by chi-square test between ^acontrol and benign breast disease, ^bbenign breast disease and breast cancer, and ^ccontrol and breast cancer)